Parminder Singh, M.D.

  1. Hematologist
  2. Internist
  3. Oncologist

Publications

  1. Petrylak DP, Vogelzang NJ, Chatta K, Fleming MT, Smith DC, Appleman LJ, Hussain A, Modiano M, Singh P, Tagawa ST, Gore I, McClay EF, Mega AE, Sartor AO, Somer B, Wadlow R, Shore ND, Olson WC, Stambler N, DiPippo VA, Israel RJ. PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study. Prostate. 2020 Jan; 80 (1):99-108 Epub 2019 Nov 19
    View PubMed
  2. Chesney J, Puzanov I, Collichio F, Milhem MM, Hauschild A, Chen L, Sharma A, Garbe C, Singh P, Mehnert JM. Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma. Br J Cancer. 2019 Aug; 121 (5):417-420 Epub 2019 July 29
    View PubMed
  3. Bin Riaz I, Umar M, Zahid U, Husnain M, Iftikhar A, McBride A, Bilal J, Javed A, Akbar S, Singh P, Ali Z, Sipra QUAR, Gondal FR, Ahman F, Anwer F. Role of one, two and three doses of high-dose chemotherapy with autologous transplantation in the treatment of high-risk or relapsed testicular cancer: a systematic review. Bone Marrow Transplant. 2018 Oct; 53 (10):1242-1254 Epub 2018 Apr 27
    View PubMed
  4. Chesney J, Puzanov I, Collichio F, Singh P, Milhem MM, Glaspy J, Hamid O, Ross M, Friedlander P, Garbe C, Logan TF, Hauschild A, Lebbe C, Chen L, Kim JJ, Gansert J, Andtbacka RHI, Kaufman HL. Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma. J Clin Oncol. 2018 Jun 10; 36 (17):1658-1667 Epub 2017 Oct 05
    View PubMed
  5. Singh P, Black P. Emerging role of checkpoint inhibition in localized bladder cancer. Urol Oncol. 2016 Dec; 34 (12):548-555 Epub 2016 Oct 21
    View PubMed
  6. Harryman WL, Hinton JP, Rubenstein CP, Singh P, Nagle RB, Parker SJ, Knudsen BS, Cress AE. The Cohesive Metastasis Phenotype in Human Prostate Cancer. Biochim Biophys Acta. 2016 Dec; 1866 (2):221-231 Epub 2016 Sept 24
    View PubMed
  7. Harryman WL, Pond E, Singh P, Little AS, Eschbacher JM, Nagle RB, Cress AE. Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers. Am J Transl Res. 2016; 8 (2):940-54 Epub 2016 Feb 15
    View PubMed
  8. Pal SK, Singh P, Vogelzang NJ. PD-1/PD-L1 in Renal Cell Carcinoma: Projecting the Way Forward. Clin Genitourin Cancer. 2015 Aug; 13 (4):257-60 Epub 2014 July 14
    View PubMed
  9. Necchi A, Pond GR, Giannatempo P, Di Lorenzo G, Eigl BJ, Locke J, Pal SK, Agarwal N, Poole A, Vaishampayan UN, Niegisch G, Hussain SA, Singh P, Bellmunt J, Sonpavde G. Cisplatin-based first-line therapy for advanced urothelial carcinoma after previous perioperative cisplatin-based therapy. Clin Genitourin Cancer. 2015 Apr; 13 (2):178-84 Epub 2014 Sept 23
    View PubMed
  10. Singh P, Pal SK, Alex A, Agarwal N. Development of PROSTVAC immunotherapy in prostate cancer. Future Oncol. 2015; 11 (15):2137-48
    View PubMed
  11. Singh P, Agarwal N, Pal SK. Sequencing systemic therapies for metastatic kidney cancer. Curr Treat Options Oncol. 2015 Jan; 16 (1):316
    View PubMed
  12. Algotar AM, Behnejad R, Singh P, Thompson PA, Hsu CH, Stratton SP. EFFECT OF SELENIUM SUPPLEMENTATION ON PROTEOMIC SERUM BIOMARKERS IN ELDERLY MEN. J Frailty Aging. 2015; 4 (2):107-10
    View PubMed
  13. Algotar AM, Hsu CH, Singh P, Stratton SP. Selenium supplementation has no effect on serum glucose levels in men at high risk of prostate cancer. J Diabetes. 2013 Dec; 5 (4):465-70 Epub 2013 May 29
    View PubMed
  14. Singh P, Algotar AM, Bracamonte ER. Prostatic small cell carcinoma: Diagnosis and management. Journal of Cancer Therapy.2013;4:804-10.
  15. Singh P, Kaur H, Lerner RG, Patel R, Rafiyath SM, Singh Lamba G. Hepatocellular carcinoma in non-cirrhotic liver without evidence of iron overload in a patient with primary hemochromatosis. Review. J Gastrointest Cancer. 2012 Mar; 43 (1):36-9
    View PubMed
  16. Lamba G, Rafiyath SM, Kaur H, Khan S, Singh P, Hamilton AM, Ang DC. Malignant glomus tumor of kidney: the first reported case and review of literature. Hum Pathol. 2011 Aug; 42 (8):1200-3 Epub 2011 Feb 18
    View PubMed
  17. Desai HV, Gandhi K, Sharma M, Jennine M, Singh P, Brogan M. Thiazide-induced severe hypercalcemia: a case report and review of literature. Am J Ther. 2010 Nov-Dec; 17 (6):e234-6
    View PubMed
  18. Gandhi K, Aronow WS, Desai H, Amin H, Sharma M, Lai HM, Singh P. Cardiovascular manifestations in patients with thrombotic thrombocytopenic purpura: a single-center experience. Clin Cardiol. 2010 Apr; 33 (4):213-6
    View PubMed
  19. Singh P, Aronow WS, Mellana WM, Gutwein AH. Prevalence of appropriate management of diabetes mellitus in an academic general medicine clinic. Am J Ther. 2010 Jan-Feb; 17 (1):42-5
    View PubMed
  20. Singh P, Sharma M, Gandhi K, Nelson J, Kaul A. Acute mesenteric vein thrombosis after laparoscopic gastric sleeve surgery for morbid obesity. Surg Obes Relat Dis. 2010 Jan-Feb; 6 (1):107-8 Epub 2009 Aug 19
    View PubMed
  21. Singh P, Lai HM, Lerner RG, Chugh T, Aronow WS. Guidelines and the use of inferior vena cava filters: a review of an institutional experience. J Thromb Haemost. 2009 Jan; 7 (1):65-71 Epub 2008 Oct 31
    View PubMed
  22. Pierre-Louis B, Singh P, Frishman WH. Acute inferior wall myocardial infarction and percutaneous coronary intervention of the right coronary during active labor: a clinical report and review of the literature. Cardiol Rev. 2008 Sep-Oct; 16 (5):260-8
    View PubMed
PST-20267249